Evidence map›Paper›PMID 30271861›Full record

ArticleRegenerative therapy2018

Congress report: A report of the 16th Congress of the Japanese Society for Regenerative Medicine.

Masaaki Kitada, Mari Dezawa

Abstract read
In one paragraph

Article in Regenerative therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Masaaki KitadaDepartment of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan.
Mari DezawaDepartment of Stem Cell Biology and Histology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, 980-8575, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 16th Congress of the Japanese Society for Regenerative Medicine was held from March 7-9, 2017, at Sendai International Center (Sendai city). The theme of this congress was "the renaissance of regenerative medicine" and it was an opportunity for information exchange between industry-leading researchers, doctors/dentists, and industry professionals. The objectives of the congress were to provide a place to promote and develop research in regenerative medicine. Numerous topics were covered in the 1 presidential lecture, 1 congress chair's lecture, 3 special lectures, the special symposia (2 sessions, 10 topics), symposia (41 sessions, 227 topics), evening symposia (3 sessions, 12 topics), joint symposium with another society (1 session, 4 topics), and presentations covering regular presentations including distinct presentations (oral presentations, 2 sessions, 8 topics), oral presentations (65 sessions, 383 topics), and poster presentations (44 sessions, 339 topics). There were co-organized seminars including 31 sessions for co-organized luncheon seminars, 2 sessions for co-organized evening seminars, and an up-to-date technology introduction corner, which hosted 153 organizations. Additionally, 4 special seminars and 3 hands-on training programs were hosted as part of the hands-on learning program for high school students during the congress. There were 3527 participants, and the event was a great success.

Indexed as

Cell therapyCongress reportRegenerative medicine

Identifiers

PMID30271861
PMCPMC6146112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.